On January 4, 2022 ChemoCentryx, Inc., (Nasdaq: CCXI), reported that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences (Press release, ChemoCentryx, JAN 4, 2022, View Source [SID1234598247]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

40th Annual J.P. Morgan Healthcare Conference
Wednesday, January 12 at 4:30 p.m. Eastern Time
H.C. Wainwright Virtual BioConnect Conference
On-demand presentation available beginning Monday, January 10 at 7:00 a.m. Eastern Time
A live audio webcast of the J.P. Morgan presentation, as well as the on-demand H.C. Wainwright presentation can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com. Replays of both presentations will be available on the Company’s website for two weeks following the respective presentation dates.